Sculptor Capital’s PetMed Express PETS Stock Holding History

Sculptor Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-92,400	Closed	-$2.17M	–	276
2019 Q4	$2.17M	Hold	92,400	–	–	0.02%	172
2019 Q3	$1.67M	Buy	+92,400	New	+$1.53M	0.02%	193
2018 Q1	–	Sell	-37,600	Closed	-$1.71M	–	120
2017 Q4	$1.71M	Hold	37,600	–	–	0.01%	209
2017 Q3	$1.25M	Buy	+37,600	New	+$1.53M	0.01%	241

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Sculptor Capital's PETS Position: Q1 2020 in Review

Sculptor Capital sold out of PetMed Express (PETS) in Q1 2020, closing a stake of 92,400 shares — an estimated $2.17M sold.

Sculptor Capital first reported a position in PETS in Q3 2017 and held it in 4 quarters. The position peaked at $2.17M in Q4 2019. 202 funds tracked by Wall St. Rank hold PETS as of Q1 2020.

Sculptor Capital reported no remaining PetMed Express position as of Q1 2020 after selling out during the quarter.
Sculptor Capital sold 92,400 PetMed Express shares in Q1 2020, an estimated $2.17M.
Sculptor Capital first reported a position in PetMed Express in Q3 2017 and held it in 4 quarters.
Sculptor Capital's PetMed Express position peaked at $2.17M in Q4 2019.
202 funds tracked by Wall St. Rank held PetMed Express as of Q1 2020.

Based on Sculptor Capital's 13F filing for Q1 2020, filed 14 May 2020.